Medicus Pharma LTD DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Medicus Pharma Ltd. is convening its Annual General and Special Meeting to seek shareholder approval for critical corporate governance amendments, auditor changes, and a significant dilutive equity financing agreement, while facing a 'going concern' uncertainty and disclosed material weaknesses in internal controls.